Global law firm White & Case LLP has advised ABG Sundal Collier AB and Carnegie Investment Bank AB, as joint bookrunners, on Q-linea AB's directed share issue.
Q-linea's board of directors agreed a directed share issue of four million shares at a subscription price of SEK 67.50 per share, which was determined through an accelerated book building.
Q-linea is an infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. The company develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases.
The White & Case team which advised on the transaction was led by partner Johan Thiman (Stockholm) and included partner Mikko Hulkko (Helsinki) and associate Christoffer Nilmen (Stockholm).
For more information, please speak to your local media contact.